227 related articles for article (PubMed ID: 23263905)
1. Predictive factors of lymph node status in small peripheral non-small cell lung cancers: tumor histology is more reliable.
Zhang Y; Sun Y; Shen L; Li Y; Xiang J; Zhang Y; Hu H; Chen H
Ann Surg Oncol; 2013 Jun; 20(6):1949-54. PubMed ID: 23263905
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.
Inoue M; Minami M; Shiono H; Sawabata N; Ideguchi K; Okumura M
J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors for node metastasis in patients with clinical stage I non-small cell lung cancer.
Cho S; Song IH; Yang HC; Kim K; Jheon S
Ann Thorac Surg; 2013 Jul; 96(1):239-45. PubMed ID: 23673071
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
[TBL] [Abstract][Full Text] [Related]
5. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of the primary tumor location based on the hilar structures in non-small cell lung cancer with mediastinal lymph node metastasis.
Ito M; Yamashita Y; Miyata Y; Ohara M; Tsutani Y; Ikeda T; Misumi K; Harada H; Omori K
Lung Cancer; 2012 Apr; 76(1):93-7. PubMed ID: 22285532
[TBL] [Abstract][Full Text] [Related]
7. Association of lymph node involvement with the prognosis of pathological T1 invasive non-small cell lung cancer.
Zhang YK; Chai ZD; Tan LL; Wang ZY; Chen ZJ; Le HB; Zhu WY
World J Surg Oncol; 2017 Mar; 15(1):64. PubMed ID: 28302176
[TBL] [Abstract][Full Text] [Related]
8. Reasonable extent of lymph node dissection in intentional segmentectomy for small-sized peripheral non-small-cell lung cancer: from the clinicopathological findings of patients who underwent lobectomy with systematic lymph node dissection.
Matsumura Y; Hishida T; Yoshida J; Aokage K; Ishii G; Nagai K
J Thorac Oncol; 2012 Nov; 7(11):1691-7. PubMed ID: 23059781
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic features in resected subcentimeter lung cancer--status of lymph node metastases.
Zhou Q; Suzuki K; Anami Y; Oh S; Takamochi K
Interact Cardiovasc Thorac Surg; 2010 Jan; 10(1):53-7. PubMed ID: 19833638
[TBL] [Abstract][Full Text] [Related]
10. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer.
Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features of small-sized non-small cell lung cancer with mediastinal lymph node metastasis.
Fukui T; Katayama T; Ito S; Abe T; Hatooka S; Mitsudomi T
Lung Cancer; 2009 Dec; 66(3):309-13. PubMed ID: 19344976
[TBL] [Abstract][Full Text] [Related]
12. Can tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastasis.
Ohta Y; Oda M; Wu J; Tsunezuka Y; Hiroshi M; Nonomura A; Watanabe G
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):900-6. PubMed ID: 11689794
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China.
Song Z; Zhu H; Guo Z; Wu W; Sun W; Zhang Y
Eur J Surg Oncol; 2013 Nov; 39(11):1262-8. PubMed ID: 24063970
[TBL] [Abstract][Full Text] [Related]
14. Involvement of lymphatic metastatic spread in non-small cell lung cancer accordingly to the primary cancer location.
Kotoulas CS; Foroulis CN; Kostikas K; Konstantinou M; Kalkandi P; Dimadi M; Bouros D; Lioulias A
Lung Cancer; 2004 May; 44(2):183-91. PubMed ID: 15084383
[TBL] [Abstract][Full Text] [Related]
15. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer.
Graham AN; Chan KJ; Pastorino U; Goldstraw P
J Thorac Cardiovasc Surg; 1999 Feb; 117(2):246-51. PubMed ID: 9918964
[TBL] [Abstract][Full Text] [Related]
16. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
[TBL] [Abstract][Full Text] [Related]
17. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
Huang GJ; Fang DK; Cheng GY; Zhang DC
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of primary lung cancer with synchronous brain metastases.
Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
[TBL] [Abstract][Full Text] [Related]
19. Systematic lymph node dissection is necessary for T1a non-small cell lung cancer.
Liu T; Liu H; Li Y
Asia Pac J Clin Oncol; 2015 Mar; 11(1):49-53. PubMed ID: 24787666
[TBL] [Abstract][Full Text] [Related]
20. [Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].
Pan TC; Zheng Z; Li J; Chen T; Liu LG; Wei X
Ai Zheng; 2007 Mar; 26(3):303-6. PubMed ID: 17355796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
